Inactivation of AdoHcy Hydrolase
J ournal of Medicinal Chemistry, 1996, Vol. 39, No. 21 4165
1/Kapp ) 1/k2 + KI/k2(1/[I])
[EtOAc/MeOH (19:1) f S1] and recrystallized (MeOH) to give
9b (70 mg, 80%): mp 241-243 °C (lit.18 mp 240-241 °C); MS
m/ z 294 (7, M+).
Con ver sion of E‚NAD+ to E‚NADH. The inhibitor-
induced E‚NADH formation was determined by measuring the
increase in absorbance at 320 nm at different time intervals
after the enzyme was mixed with the inhibitor. To AdoHcy
hydrolase (44 µM) in 1 mL of 50 mM phosphate buffer (pH
7.2) containing 1 mM EDTA (buffer A) was added 100 µL of
Ado 5′-ester 2b (22 mM), with mixing for 10 s. The UV
spectrum (280-500 nm) was recorded periodically at 25 °C
using a HP 8452 diode array spectrophotometer. The reference
cell contained the same enzyme solution to which had been
added 100 µL of water. Spectra were recorded until no
increase in absorbance at 320 nm was observed (∼20 min).
Sp on ta n eou s Hyd r olysis of th e Ad o 5′-Ester 2b a n d
Ad o 5′-Am id e 8b. Hydrolyses of ester 2b and amide 8b were
studied by incubation in buffer A (with and without enzyme)
at 37 °C for various times. At each time point, an aliquot (30
µL) of the reaction solution was injected into a C-18 reversed-
phase HPLC column (Econosphere Alltech, 250 × 4.6 mm).
Chromatography was carried out with a linear gradient of
8-20% A in B for 0-15 min at a flow rate of 1 mL/min, where
mobile phase A was acetonitrile and B was 50 mM sodium
phosphate buffer (pH 3.2) containing 10 mM heptanesulfonic
acid. Peak areas of the product and remaining reactant were
monitored by UV at 258 nm. Kinetic data were fitted to a
first-order reaction equation.
Ad en osin e-5′-(N-bu tylca r boxa m id e) (10b). Ester 2a
(100 mg, 0.3 mmol) was suspended in dioxane (5 mL),
butylamine (1 mL) was added, and the mixture was stirred at
ambient temperature for 2 h. TLC (S1) showed a mixture of
10a /2a (∼3:2). MeOH (2 mL) and H2O (0.5 mmol) were added,
the reaction mixture was gently refluxed for 2 h, and volatiles
were evaporated. The residue was deprotected (as described
for 8b), chromatographed [EtOAc/MeOH (19:1) f S1], and
crystallized (MeOH/EtOAc, 2:1) to give 10b (62 mg, 62%): mp
122-124 °C (lit.18 mp 125 °C); MS m/ z 336 (10, M+).
Ad en osin e-5′-(N-ben zylca r boxa m id e) (11b). Ester 2a
(67 mg, 0.2 mmol) and benzylamine (0.22 mL, 214 mg, 2 mmol)
in dioxane/MeOH (1:1, 10 mL) were refluxed for 4 h. Depro-
tection, purification, and crystallization (MeOH/H2O, 1:1) (as
described for 10b) gave 11b (53 mg, 72%): mp 133-134 °C
(lit.18 mp 130-133 °C); MS m/ z 370 (20, M+).
Ad en osin e-5′-(N-p h en ylca r boxa m id e) (12b). A solution
of 1a (64 mg, 0.2 mmol) in MeOH/dioxane/H2O (3:3:1, 10 mL)
was added to a solution of aniline (45 µL, 46 mg, 0.5 mmol)
and dicyclohexylcarbodiimide (82 mg, 0.4 mmol) in THF (3
mL), and stirring was continued overnight at ambient tem-
perature. Volatiles were evaporated in vacuo, and the residue
was chromatographed [EtOAc/MeOH (19:1) f S1] to give 12a
(68 mg). This 12a (68 mg) was deprotected (as described for
8b) and crystallized (MeOH/EtOAc, 1:1) to give 12b (58 mg,
81%): mp 246-248 °C (lit.18 mp 252-254 °C); MS m/ z 356
(22, M+).
Ad en osin e-5′-(N,N-d ieth ylca r boxa m id e) (14b). Treat-
ment of 1a (160 mg, 0.5 mmol) with thionyl chloride (0.50 mL,
0.81 mg, 6.8 mmol) and DMF (2 drops) gave the acid chloride
13a as described.16 Et2NH (1 mL) was added dropwise at 0 °C
to this 13a in THF (2 mL), and stirring was continued at
ambient temperature for 2 h. The solution was evaporated,
the residue was partitioned (HCl/H2O/CHCl3), and the organic
layer was washed (NaHCO3/H2O, brine), dried (MgSO4), and
evaporated to give 14a (yellow oil). Deprotection of this 14a
(as described for 8b), chromatography [EtOAc/MeOH (19:1)
f S1], and crystallization (MeOH) gave 14b (104 mg, 62% from
1a ): mp 244-245 °C; UV max 259 nm (ꢀ 15 100), min 230 nm
(ꢀ 4100); 1H NMR 1.07 and 1.12 (t and t, J ) 7.0 Hz, 3 and 3,
CH3′s), 3.28-3.45 (m, 4, CH2′s), 4.28 (ddd, J 3′-4′ ) 2.9 Hz, J OH-3′
) 5.6 Hz, J 3′-2′ ) 4.4 Hz, 1, H3′), 4.54 (ddd, J 2′-1′ ) 5.8 Hz,
J OH-2′ ) 5.7 Hz, 1, H2′), 4.77 (d, 1, H4′), 5.65 (d, 1, OH3′), 5.68
(d, 1, OH2′), 6.07 (d, 1, H1′), 7.32 (br s, 2, NH2), 8.18 (s, 1,
H2), 8.59 (s, 1, H8); MS m/ z 336 (20, M+). Anal. (C14H20N6O4)
C,H,N.
Deter m in a tion of Ad oHcy Hyd r ola se In h ibition Con -
sta n ts. The purified recombinant human placental AdoHcy
hydrolase was prepared from Escherichia coli carrying the
expression vector (pPUCSAH) and grown in the presence of
isopropyl â-D-thiogalactopyranoside essentially as described.24
The enzyme activity was determined in the synthetic direction
by incubating AdoHcy hydrolase with 0.2 mM Ado and 5 mM
Hcy for 5 min at 37 °C in 50 mM potassium phosphate buffer
(pH 7.2) containing 1 mM EDTA and assaying the reaction
product, AdoHcy, by HPLC after quenching the reaction by
addition of perchloric acid (final concentration: 0.5 M). An
aliquot (100 µL) of the reaction mixture was injected into a
HPLC column (Econosphere Alltech, 25 cm × 4.6 mm, C-18
reversed-phase column) at a flow rate of 1 mL/min. The
elution gradient consisted of two sequential linear gradients:
6-15% B over 0-9 min and 15-50% B over 9-15 min, where
the mobile phase B was acetonitrile and A was 50 mM sodium
phosphate buffer (pH 3.2) containing 10 mM heptanesulfonic
acid. The peak of AdoHcy was detected by UV at 254 nm. For
the determination of inhibition constants, AdoHcy hydrolase
was preincubated with various concentrations of the inhibitors
for various time intervals and the remaining enzyme activity
Ack n ow led gm en t. We thank the American Cancer
Society (Grant No. DHP-34), Brigham Young University
development funds, and the United States Public Health
Service (Grant No. GM-29332) for financial support and
Mrs. J eanny K. Gordon for assistance with the manu-
script.
Su p p or tin g In for m a tion Ava ila ble: Kitz and Wilson
plots for AdoHcy hydrolase inhibition kinetic data in Table 2
and UV absorbance vs time plots for reduction of NAD+ to
NADH upon incubation of 2b with the enzyme (13 pages).
Ordering information is given on any current masthead page.
Refer en ces
(1) Ueland, P. M. Pharmacological and Biochemical Aspects of
S-Adenosylhomocysteine and S-Adenosylhomocysteine Hydro-
lase. Pharmacol. Rev. 1982, 34, 223-253.
(2) (a) De Clercq, E. S-Adenosylhomocysteine Hydrolase Inhibitors
as Broad-Spectrum Antiviral Agents. Biochem. Pharmacol. 1987,
36, 2567-2575. (b) Yuan, C.-S.; Liu, S.; Wnuk, S. F.; Robins, M.
J .; Borchardt, R. T. Design and Synthesis of S-Adenosylho-
mocysteine Hydrolase Inhibitors as Broad-Spectrum Antiviral
Agents. In Advances in Antiviral Drug Design; DeClercq, E., Ed.;
J AI Press: Greenwich, CT, 1996; Vol. 2, pp 41-88.
(3) (a) Wolfe, M. S.; Borchardt, R. T. S-Adenosyl-L-homocysteine
Hydrolase as a Target for Antiviral Chemotherapy. J . Med.
Chem. 1991, 34, 1521-1529. (b) Liu, S.; Wolfe, M. S.; Borchardt,
R. T. Rational Approaches to the Design of Antiviral Agents
Based on S-Adenosyl-L-homocysteine Hydrolase as a Molecular
Target. Antiviral Res. 1992, 19, 247-265.
(4) (a) Keller, B. T.; Borchardt, R. T. Metabolism and Mechanism
of Action of Neplanocin A - A Potent Inhibitor of S-Adenosyl-
homocysteine Hydrolase. In Biological Methylation and Drug
Design; Borchardt, R. T., Creveling, C. R., Ueland, P. M., Eds.;
Humana Press: Clifton, NJ , 1986; pp 385-396. (b) Keller, B.
T.; Borchardt, R. T. Inhibition of S-Adenosylmethionine-depend-
ent Transmethylation as an Approach to the Development of
Antiviral Agents. In Antiviral Drug Development: A Multidis-
ciplinary Approach; DeClercq, E., Walker, R. T., Eds.; Plenum:
New York, 1988; pp 123-138. (c) Ransohoff, R. M.; Narayan,
P.; Ayers, D. F.; Rottman, F. M.; Nilsen, T. W. Priming of
Influenza mRNA Transcription Is Inhibited in CHO Cells
Treated with the Methylation Inhibitor, Neplanocin A. Antiviral
Res. 1987, 7, 317-327.
(5) (a) Hasobe, M.; McKee, J . G.; Borchardt, R. T. Relationship
between Intracellular Concentration of S-Adenosylhomocysteine
and Inhibition of Vaccinia Virus Replication and Inhibition of
Murine L-929 Cell Growth. Antimicrob. Agents Chemother. 1989,
33, 828-834. (b) Cools, M.; De Clercq, E. Influence of S-
Adenosylhomocysteine Hydrolase Inhibitors on S-Adenosylho-
mocysteine and S-Adenosylmethionine Pool Levels in L929 Cells.
Biochem. Pharmacol. 1990, 40, 2259-2264.
was measured. The pseudo-first-order rate constants (Kapp
)
were obtained from the plot of log(% activity remaining) vs
time, and KI and k2 values (Table 1) were estimated from the
double-reciprocal plot of 1/Kapp vs 1/[inhibitor] using the
following equation: